Scopus Bio Pharma Inc. reported raising $9.75 Million in an initial SEC Form D filing, from an offering of $9.75 Million
Amount Raised
$9.75 Million
Round Type
Venture
New YorkHealthcareQuick answer
Scopus BioPharma Inc. raised $9.75 Million in a funding round, dated December 7, 2021. Scopus BioPharma Inc. is based in New York, New York, United States.
- How much did Scopus BioPharma Inc. raise?
- Scopus BioPharma Inc. raised $9.75 Million in a funding round on December 7, 2021.
- What does Scopus BioPharma Inc. do?
- Scopus BioPharma - Creating the Future of Therapeutics
- Where is Scopus BioPharma Inc. based and how big is it?
- Scopus BioPharma Inc. is based in New York, New York, United States.
Source: Fundz verified event record.
Who else raised in Healthcare around the same time
Companies in the same sectors as Scopus BioPharma Inc. that raised within 45 days of this round, from Fundz verified event records.
- Regen Osteo, Inc raised an undisclosed amount on January 21, 2022.
- Medically Home raised $110M on January 21, 2022.
- Tesis Labs LLC raised $16M on January 20, 2022.
- Windgap Medical raised $39M (Series B) on January 20, 2022.
- Hoy Health Corp raised $1M (Seed) on January 20, 2022.
- Equilibre BioPharmaceuticals Corp raised $16M on January 20, 2022.
Who to call at Scopus BioPharma Inc., and when
A new round usually means Scopus BioPharma Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Scopus BioPharma Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Scopus BioPharma Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Scopus BioPharma Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Scopus BioPharma Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Scopus BioPharma Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.